Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
The Motley Fool reports that 58% of individual investors plan to buy more stocks in 2026, driven by AI optimism, despite economic concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results